['hypercholesterolemia']
['bempedoic acid 180mg', 'ezetimibe 10mg', 'atorvastatin 20mg']

        Inclusion Criteria:

          -  Fasting LDL-cholesterol between 130 - 189 mg/dL at screening following washout of all
             LDL-C-lowering drugs and nutritional supplements

          -  Men and nonpregnant, nonlactating women

          -  Sufficiently stable and suitable to undergo washout of all LDL-C-lowering drugs and
             nutritional supplements for 12 weeks

        Exclusion Criteria:

          -  Fasting blood triglycerides greater than or equal to 400 mg/dL

          -  Body Mass Index (BMI) greater than 50 kg/m2

          -  History of clinically significant cardiovascular disease

          -  History of type 1 or type 2 diabetes
      